Moralès, Olivier <br/><br/>
EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)  Apr 2012 
 - 254-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-4513 
<br/><br/><label>Standard No.: </label>10.1097/CJI.0b013e31824d72c5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Line<br/>Cytokines--biosynthesis<br/>Cytotoxicity, Immunologic<br/>Granzymes--metabolism<br/>Humans<br/>Immunologic Memory<br/>Peptides--chemistry<br/>T-Lymphocytes, Cytotoxic--immunology<br/>T-Lymphocytes, Regulatory--immunology<br/>Th1 Cells--immunology<br/>Viral Matrix Proteins--chemistry